Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will undertake a review of the adequacy of targets based on the staging of solid tumours for the early diagnosis of blood cancers in patients.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department continues to support the National Health Service to diagnose and treat cancer as early and fast as possible. There have been improvements in the prognosis of blood cancer patients, with patients now living twice as long. However, we recognise that because of the damaged NHS this Government inherited, patients with cancers with non-specific symptoms such as blood cancer, are waiting too long for diagnosis and subsequent treatment.
There are no current plans to introduce a specific proxy staging measure or a corresponding national target to support the earlier diagnosis of blood cancers. However, the Department will continue to engage with blood cancer charities and key stakeholders to determine how to support the best outcomes for blood cancer patients.
At this time no current assessment has been made on the potential merits of a proxy measure for early diagnosis in unstageable blood cancers. However, we remain committed to making improvements across different cancer types and reducing disparities in cancer survival. Early cancer diagnosis is also a specific priority within the NHS’s wider Core20Plus5 approach to reducing healthcare inequalities. The NHS currently track early diagnosis in stageable blood cancers by combining the percentage of diagnoses within stage 1 or 2, as it would for any other stageable cancer.
Furthermore, to tackle late, emergency setting diagnoses of blood cancers, the NHS is implementing non-specific symptom (NSS) pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type. There are currently 115 NSS services operating in England with blood cancers being one of the most common cancer types diagnosed through these pathways.
The National Disease Registration Service (NDRS), through the National Cancer Registration and Analysis Services, collects information on how many people in England have cancer. Blood cancer is included as a distinct category, labelled haematological neoplasms. The NDRS website also shows the number of people treated for different tumour types by treatment type, as well as survival rates, mortality rates, and data on urgent suspected cancer referrals. Further information is available at the following link:
https://digital.nhs.uk/ndrs/data/data-outputs/cancer-data-hub
The National Cancer Plan will include further details on improving outcomes for cancer patients in England, as well as speeding up diagnosis and treatment. It will ensure patients, including those with blood cancer, have timely access to the latest treatments and technology.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help reduce the number of blood cancer patients diagnosed through A&E.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department continues to support the National Health Service to diagnose and treat cancer as early and fast as possible. There have been improvements in the prognosis of blood cancer patients, with patients now living twice as long. However, we recognise that because of the damaged NHS this Government inherited, patients with cancers with non-specific symptoms such as blood cancer, are waiting too long for diagnosis and subsequent treatment.
There are no current plans to introduce a specific proxy staging measure or a corresponding national target to support the earlier diagnosis of blood cancers. However, the Department will continue to engage with blood cancer charities and key stakeholders to determine how to support the best outcomes for blood cancer patients.
At this time no current assessment has been made on the potential merits of a proxy measure for early diagnosis in unstageable blood cancers. However, we remain committed to making improvements across different cancer types and reducing disparities in cancer survival. Early cancer diagnosis is also a specific priority within the NHS’s wider Core20Plus5 approach to reducing healthcare inequalities. The NHS currently track early diagnosis in stageable blood cancers by combining the percentage of diagnoses within stage 1 or 2, as it would for any other stageable cancer.
Furthermore, to tackle late, emergency setting diagnoses of blood cancers, the NHS is implementing non-specific symptom (NSS) pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type. There are currently 115 NSS services operating in England with blood cancers being one of the most common cancer types diagnosed through these pathways.
The National Disease Registration Service (NDRS), through the National Cancer Registration and Analysis Services, collects information on how many people in England have cancer. Blood cancer is included as a distinct category, labelled haematological neoplasms. The NDRS website also shows the number of people treated for different tumour types by treatment type, as well as survival rates, mortality rates, and data on urgent suspected cancer referrals. Further information is available at the following link:
https://digital.nhs.uk/ndrs/data/data-outputs/cancer-data-hub
The National Cancer Plan will include further details on improving outcomes for cancer patients in England, as well as speeding up diagnosis and treatment. It will ensure patients, including those with blood cancer, have timely access to the latest treatments and technology.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the early (a) detection and (b) diagnosis of blood cancer.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department continues to support the National Health Service to diagnose and treat cancer as early and fast as possible. There have been improvements in the prognosis of blood cancer patients, with patients now living twice as long. However, we recognise that because of the damaged NHS this Government inherited, patients with cancers with non-specific symptoms such as blood cancer, are waiting too long for diagnosis and subsequent treatment.
There are no current plans to introduce a specific proxy staging measure or a corresponding national target to support the earlier diagnosis of blood cancers. However, the Department will continue to engage with blood cancer charities and key stakeholders to determine how to support the best outcomes for blood cancer patients.
At this time no current assessment has been made on the potential merits of a proxy measure for early diagnosis in unstageable blood cancers. However, we remain committed to making improvements across different cancer types and reducing disparities in cancer survival. Early cancer diagnosis is also a specific priority within the NHS’s wider Core20Plus5 approach to reducing healthcare inequalities. The NHS currently track early diagnosis in stageable blood cancers by combining the percentage of diagnoses within stage 1 or 2, as it would for any other stageable cancer.
Furthermore, to tackle late, emergency setting diagnoses of blood cancers, the NHS is implementing non-specific symptom (NSS) pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type. There are currently 115 NSS services operating in England with blood cancers being one of the most common cancer types diagnosed through these pathways.
The National Disease Registration Service (NDRS), through the National Cancer Registration and Analysis Services, collects information on how many people in England have cancer. Blood cancer is included as a distinct category, labelled haematological neoplasms. The NDRS website also shows the number of people treated for different tumour types by treatment type, as well as survival rates, mortality rates, and data on urgent suspected cancer referrals. Further information is available at the following link:
https://digital.nhs.uk/ndrs/data/data-outputs/cancer-data-hub
The National Cancer Plan will include further details on improving outcomes for cancer patients in England, as well as speeding up diagnosis and treatment. It will ensure patients, including those with blood cancer, have timely access to the latest treatments and technology.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 July 2025 to Question 67468 on Diseases: Undocumented Migrants, what information her Department holds on the number of irregular migrants who were found to have an infectious disease upon arrival in each of the last three years.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK Health Security Agency (UKHSA) does not routinely collect or hold data on communicable disease by visa status for new arrivals to the United Kingdom. However, if an outbreak occurs, data associated with outbreak cases may be collected.
There was an outbreak of diphtheria among this group in 2022 and 2023. Monthly data on these cases is published by UKHSA and is available at the following link: https://www.gov.uk/government/publications/diphtheria-cases-among-asylum-seekers-in-england-2022/diphtheria-cases-among-asylum-seekers-in-england-weekly-data-tables
No cases were reported in 2024, and two cases have been confirmed so far in 2025.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to provide funding for (a) adult and (b) children’s hospices for the next ten years.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We are supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care. We are also providing £26 million of revenue funding to support children and young people’s hospices for 2025/26. This is a continuation of the funding which until recently was known as the children and young people’s hospice grant. In 2024/25 and 2025/26, this funding was administered via integrated care boards in line with National Health Service devolution.
The Department and NHS England are currently looking at how to improve the access, quality and sustainability of all-age palliative and end of life care in line with the 10-Year Health Plan.
Officials will present further proposals to Ministers over the coming months, outlining the drivers and incentives that are required in palliative care and end of life care to enable the shift from hospital to community, including as part of neighbourhood health teams.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve (a) education about and (b) awareness of endometriosis.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government recognises the challenges faced by women with endometriosis and the impact it has on their lives, their relationships, and their participation in education and the workforce.
On 15 July, the Department for Education published the revised Relationships Education, Relationships and Sex Education and Health Education (RSHE) statutory guidance, which stipulates that secondary school RSHE lessons should cover menstrual and gynaecological health, covering aspects such as what is an average period, conditions including endometriosis and polycystic ovary syndrome, and when to seek help from healthcare professionals. This revised guidance emphasises the importance of ensuring that pupils have a comprehensive understanding of women’s health topics.
The General Medical Council has introduced the Medical Licensing Assessment to encourage a better understanding of common women’s health problems among all doctors as they start their careers in the United Kingdom. The content map for this assessment includes several topics relating to women’s health, including menstrual problems, endometriosis, menopause, and urinary incontinence. This will encourage a better understanding of common women’s health problems among all doctors as they start their careers in the UK.
Endometriosis is also included in the core curriculum for trainee general practitioners, and for obstetricians and gynaecologists. In November 2024, the National Institute for Health and Care Excellence updated their guideline on endometriosis which makes firmer recommendations for healthcare professionals on referral and investigations for women with a suspected diagnosis, which is available at the following link:
https://www.nice.org.uk/guidance/NG73)www.nice.org.uk/guidance/NG73
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help reduce waiting times for radiotherapy treatment.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Radiotherapy is vital in cancer care, and it remains a key priority for the Government to reduce radiotherapy waiting times and provide the highest quality of treatment available. This is why the Government has invested £70 million of central funding on 28 new radiotherapy machines across the country to replace older machines. These new machines are more efficient meaning that more patients can be seen more quickly. This will help to reduce waiting times for cancer patients.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent discussions he has had with hospice providers on the increase in financial pressures they face.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We are supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care. We are also providing £26 million of revenue funding to support children and young people’s hospices for 2025/26. This is a continuation of the funding which until recently was known as the children and young people’s hospice grant. In 2024/25 and 2025/26, this funding was administered via integrated care boards in line with National Health Service devolution.
The Department and NHS England are looking at how to improve the access, quality, and sustainability of all-age palliative care and end of life care, including hospice provision, in line with the 10-Year Health Plan.
The Government and the NHS will closely monitor the shift towards the strategic commissioning of palliative care and end of life care services, including from hospices, to ensure that the future state of services reduces variation in access and quality, although some variation may be appropriate to reflect both innovation and the needs of local populations.
Officials will present further proposals to ministers over the coming months, outlining how to operationalise the required changes to palliative care and end of life care to enable the shift from hospital to community, including as part of neighbourhood health teams. Hospices will play an important role in that shift.
The Department and NHS England will continue to proactively engage with our stakeholders, including the voluntary sector and independent hospices, on an ongoing basis, to understand the issues and pressures they face.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to support hospices with the increase in (a) the level of inflation and (b) staffing costs and (c) energy prices.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We are supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care. We are also providing £26 million of revenue funding to support children and young people’s hospices for 2025/26. This is a continuation of the funding which until recently was known as the children and young people’s hospice grant. In 2024/25 and 2025/26, this funding was administered via integrated care boards in line with National Health Service devolution.
The Department and NHS England are looking at how to improve the access, quality, and sustainability of all-age palliative care and end of life care, including hospice provision, in line with the 10-Year Health Plan.
The Government and the NHS will closely monitor the shift towards the strategic commissioning of palliative care and end of life care services, including from hospices, to ensure that the future state of services reduces variation in access and quality, although some variation may be appropriate to reflect both innovation and the needs of local populations.
Officials will present further proposals to ministers over the coming months, outlining how to operationalise the required changes to palliative care and end of life care to enable the shift from hospital to community, including as part of neighbourhood health teams. Hospices will play an important role in that shift.
The Department and NHS England will continue to proactively engage with our stakeholders, including the voluntary sector and independent hospices, on an ongoing basis, to understand the issues and pressures they face.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the funding model for hospices in England.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We are supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care. We are also providing £26 million of revenue funding to support children and young people’s hospices for 2025/26. This is a continuation of the funding which until recently was known as the children and young people’s hospice grant. In 2024/25 and 2025/26, this funding was administered via integrated care boards in line with National Health Service devolution.
The Department and NHS England are looking at how to improve the access, quality, and sustainability of all-age palliative care and end of life care, including hospice provision, in line with the 10-Year Health Plan.
The Government and the NHS will closely monitor the shift towards the strategic commissioning of palliative care and end of life care services, including from hospices, to ensure that the future state of services reduces variation in access and quality, although some variation may be appropriate to reflect both innovation and the needs of local populations.
Officials will present further proposals to ministers over the coming months, outlining how to operationalise the required changes to palliative care and end of life care to enable the shift from hospital to community, including as part of neighbourhood health teams. Hospices will play an important role in that shift.
The Department and NHS England will continue to proactively engage with our stakeholders, including the voluntary sector and independent hospices, on an ongoing basis, to understand the issues and pressures they face.